COMMUNIQUÉS West-GlobeNewswire

Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights
13/05/2026
Phase 1 proof-of-mechanism study of EQ504 on track to initiate in mid-2026, with data expected approximately six months thereafter Equillium appoints Snehal Naik, Ph.D., as Chief Development Officer to lead clinical [...]
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
13/05/2026
Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million Emrosi ® revenues were $6.3 million in the first quarter ended March 31, 2026 Cash position increased to $27 [...]
aTyr Pharma to Participate in Upcoming Investor Conferences
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA [...]
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
13/05/2026
Manufacturing operations divestiture sharpens focus on core capabilities in novel drug discovery and development Manufacturing divestiture and expanded monetization of ZYNYZ royalty anticipated to provide up to $202.5 [...]
Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
13/05/2026
Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026 Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union, and the United [...]
Medicenna Announces the Launch of a Marketed Public Offering of Securities
13/05/2026
NOT FOR DISSEMINATION INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO and HOUSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA), a [...]
Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc. (NASDAQ: BLTE), (“Belite Bio®” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics [...]
Mdxhealth Reports Q1-2026 Results
13/05/2026
Mdxhealth Reports Q1-2026 Results Conference call with Q&A today at 4:30 PM ET / 22:30 CET IRVINE, California – May 13, 2026 ( GlobeNewswire ) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
13/05/2026
COPENHAGEN, Denmark, May 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial [...]
LogicMark, Inc. Announces Strong First Quarter 2026 Results
13/05/2026
Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows LOUISVILLE, Ky., May 13, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK) (the “Company”), a provider of personal safety and emergency [...]
Berry Street Partners with Factor, Bringing Personalized Nutrition Therapy to Leading Meal Delivery Service
13/05/2026
Factor’s expansive customer base can now work with expert Registered Dietitians who see their actual meal choices, turning every session into targeted recommendations NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- Berry [...]
MAPS Announces Dates for Psychedelic Science 2027; Early Bird Registrations Now Open
13/05/2026
Early bird registration is now open for Psychedelic Science 2027, taking place May 3–7, 2027, in Denver, Colorado. Early bird pricing offers discounted registration in limited quantities to the world’s leading [...]
Chengdu Origen and Vanotech Announce KHN921 Investigational New Drug application clearance by the US FDA for the treatment of hypertrophic cardiomyopathy (HCM) associated with MYBPC3 mutations
13/05/2026
Investigational New Drug application for KHN921 received “study may proceed” from the US FDA. KHN921 is a potential "first-in-class" cardiovascular AAV gene therapy being developed for the treatment of hypertrophic [...]
AB Science reports its revenues for the year 2025 and provides an update on its activities
13/05/2026
PRESS RELEASE AB SCIENCE PRESENTS ITS ANNUAL FINANCIAL RESULTS AS OF 31 DECEMBER 2025 AND KEY EVENTS FOR THE PERIOD Financial and corporate position Operating loss of €3.8 million as of 31 December 2025, down 38% [...]
AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2025 et présente un point sur ses activités
13/05/2026
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS ANNUELS AU 31 DECEMBRE 2025 ET LES EVENEMENTS CLEFS DE LA PERIODE Situation financière et corporate Déficit opérationnel de 3,8 millions d’euros au 31 [...]
JavaTide Claims Evaluated: Investigating the Java Tide Ingredients for Purity and Potency
13/05/2026
JavaTide Prebiotic and Probiotic Weight Loss Support: Chicory Root Inulin, Resistant Starch, and Akkermansia muciniphila for Gut Health and Metabolism Explained Largo, FL, May 13, 2026 (GLOBE NEWSWIRE) -- These [...]
Ipsen S.A. – Evolution de la composition du Conseil d’administration
13/05/2026
Ipsen S.A. – Evolution de la composition du Conseil d’administration PARIS, FRANCE, 13 MAI 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) annonce aujourd'hui que Madame Karen Witts a remis sa démission de son mandat d’ [...]
Ipsen S.A. – Evolution of the composition of the Board of Directors
13/05/2026
Ipsen S.A. – Evolution of the composition of the Board of Directors PARIS, FRANCE, 13 MAY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that Mrs. Karen Witts has resigned from her position as a Director of [...]
Comprehensive Healthcare Names New COO and CHRO to Strengthen Growing Organization
13/05/2026
YAKIMA, Wash., May 13, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare, the leading community behavioral health provider in central and southwest Washington, today announced a promotion and an addition to its [...]

Pages